Skip to main content

Table 1 Baseline clinical and laboratory characteristics according to the presence of vasospastic angina (VA)

From: Blunted heart rate recovery is associated with coronary artery spasm in patients with suspected vasospastic angina

  Patients without VA (n = 676) Patients with VA (n = 300) p-value
Age, years 53.2 ± 10.9 55.7 ± 9.8 <0.001
Male gender, n (%) 278 (41.1%) 186 (62%) <0.001
Body mass index, kg/m2 24.6 ± 3.3 24.7 ± 3.2 0.681
systolic BP, mmHg 147.3 ± 24.1 148.2 ± 24.1 0.568
diastolic BP, mmHg 74.1 ± 13.2 74.3 ± 12.4 0.784
Current smoking, n (%) 159 (23.5%) 135 (45%) <0.001
Alcohol drinker, n (%) 216 (32%) 124 (41.3%) 0.006
Diabetes mellitus, n (%) 78 (11.6%) 49 (16.3%) 0.052
Dyslipidemia, n (%) 287 (42.5%) 156 (52%) 0.007
Hypertension, n (%) 200 (29.6%) 90 (30%) 0.956
Hyperthyroidism, n (%) 28 (7.5%) 8 (5.3%) 0.466
Previous medication
 Aspirin 106 (15.8%) 44 (14.7%) 0.752
 RAS blocker 89 (13.2%) 52 (17.3%) 0.109
 Beta blocker 67 (9.9%) 36 (12%) 0.390
 Calcium channel blocker 91 (13.5%) 45 (15%) 0.601
 Diuretics 19 (2.8%) 9 (3%) 1.000
 Nitrates 65 (9.7%) 44 (14.7%) 0.029
 Statin 83 (12.4%) 57 (19%) 0.009
Uric acid, mg/L 5.4 ± 1.5 5.5 ± 1.5 0.492
Creatinine, mg/dL 0.8 ± 0.2 0.8 ± 0.2 0.973
Fasting glucose, mg/dL 101.9 ± 24.9 98.6 ± 19.5 0.054
Total cholesterol, mg/dL 176.5 ± 37.1 174.2 ± 35.3 0.375
LDLcholesterol, mg/dL 105.2 ± 36.0 103.1 ± 31.2 0.391
HDL cholesterol, mg/dL 47.7 ± 14.5 47.3 ± 13.0 0.647
Triglycerides, mg/dL 124.7 ± 120.1 131.6 ± 103.4 0.386
hs-CRP, mg/dL 0.3 ± 1.0 0.3 ± 1.3 0.973
  1. All values are means ± SDs for continuous variables or frequencies (percentages) for categorical variables
  2. BP blood pressure, RAS renin angiotensin system, LDL low density lipoprotein, HDL high density lipoprotein, hs-CRP high sensitivity C-reactive protein